Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease

Anker SD, Ji L, Kindel T, Coats AJ, Ojji D, Barragán AP, Rossing P, Zieroth S, Ahmad S, Usman S, Appannah G, Bailey AL, Bennis[...]

The frequency and impact of previous admissions within 90 days of subsequent hospitalization for acute myocarditis: An analysis of the Nationwide readmission database

Afzal A, Qureshi A, Bozkurt B, Fonarow GC, Lip GYH, Kwok CS. The frequency and impact of previous admissions within 90 days of subsequent hospitalization[...]

Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity

Shakil SS, Hsue PY. Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity. Circ Heart Fail. 2026 Mar 11:e014088. doi: 10.1161/CIRCHEARTFAILURE.126.014088. Epub ahead of[...]